Delivery Order SPE2DB20D2014-SPE2DB24FC35V

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,749.26, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This is a delivery order contract with a firm fixed price pricing type, with a completion date of July 15, 2024. The contract does not have a set-aside designation....
This federal contract award is for the delivery of AIMOVIG 140 MG/ML autoinjector medical supplies to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves numerous government agencies. The firm-fixed-price delivery order has a ceiling value of $2,713.59 and a completion date of September 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,170.36 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,371.23 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024. The contract has a period of performance through June 26, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,715.72 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical and medical supplies to the U.S. government. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,878.03, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 2, 2024 with a ceiling value of $6,434.16. This is a firm fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $6,999.02 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, with no set-aside designation. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has a ceiling value of $3,168.34 and is a firm fixed-price delivery order, with a completion date of June 17, 2024. This award is part of a...
This federal contract award is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $4,523.36 and is a firm fixed-price delivery order that runs through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC35V
    Delivery Order

This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,711.46, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government.

The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of July 1, 2024. Amerisourcebergen Drug Corp, through its Corporate Office Division, will be responsible for fulfilling this order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This latest contract award is not designated as a set-aside.

Generated 9/27/24, 9:22 AM